CREATININE— 510(k) K061193

Substantially Equivalent

Abbott Laboratories, Inc.

FDA 510(k) clearance K061193 for CREATININE, Substantially Equivalent on 2006-06-23. Applicant: Abbott Laboratories, Inc..

Clearance details

Applicant: Abbott Laboratories, Inc.
Product code: Code CGX
Advisory panel: Clinical Chemistry
Date received: 2006-04-28
Decision date: 2006-06-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Irving, TX, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.